PPD, Inc. (Thermo Fisher Scientific Clinical Research)

PPD, Inc. is a global clinical research organization that provides clinical development, laboratory services, regulatory support, and research solutions for pharmaceutical, biotechnology, and healthcare companies. Founded in 1985 and headquartered in Wilmington, North Carolina, United States, PPD became part of Thermo Fisher Scientific in 2021, expanding Thermo Fisher’s capabilities in clinical research and drug development services.

PPD specializes in managing complex clinical trials across all phases of development, including Phase I–IV studies, clinical operations, patient recruitment, clinical data management, biostatistics, regulatory consulting, pharmacovigilance, and laboratory services. The organization supports sponsors developing innovative medicines across therapeutic areas such as oncology, vaccines, immunology, infectious diseases, and rare conditions.

Through Thermo Fisher Scientific’s global healthcare ecosystem, PPD provides integrated clinical research solutions combining clinical expertise, laboratory capabilities, technology platforms, and scientific services. The company helps pharmaceutical and biotechnology organizations accelerate drug development while maintaining high standards of quality, safety, and compliance.

PPD operates a worldwide network of clinical research professionals, investigators, laboratories, and healthcare sites. Its technology-enabled solutions support efficient trial execution, improved patient recruitment, and better management of clinical data.

The organization follows global clinical research standards, including Good Clinical Practice (GCP), FDA requirements, EMA regulations, ICH guidelines, and international quality management systems.

With decades of experience in clinical research and drug development, PPD continues to support healthcare innovators by providing reliable clinical trial services that help bring new therapies from discovery to patients.